DISCERN™, A Highly Accurate, Minimally Invasive Test To Diagnose Alzheimer’s Disease
[ad_1] DISCERN™, A Highly Accurate, Minimally Invasive Test To Diagnose Alzheimer’s Disease November 14, 2023 by Alzheimer’s Speaks Frank Amato, CEO and President, SYNAPS Dx, which offers DISCERN™, the first highly accurate, minimally invasive test supporting a clinician’s definitive diagnosis of AD versus other forms of dementia, even in people recently diagnosed with dementia. DISCERN is … Read more